VEDANTA BIOSCIENCES, INC.

Profile

Company Names

VEDANTA BIOSCIENCES, INC.

Addresses

19 BLACKSTONE STREET, CAMBRIDGE, MA 02139

19 BLACKSTONE STREET, THIRD FLOOR, CAMBRIDGE, MA 02139

Phone Numbers

857 706 1427

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, OTHER HEALTH CARE

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$240,301,373.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2023-03-01 
$118,500,000.00 
$118,500,000.00 
$0.00 
Debt 
3
2021-07-16 
$68,406,915.00 
$74,999,998.00 
$6,593,083.00 
Equity 
2
2019-09-11 
$7,999,939.00 
$16,570,052.00 
$8,570,113.00 
Equity 
1
2018-12-21 
$45,394,519.00 
$49,999,988.00 
$4,605,469.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
BHARATT 
 
CHOWRIRA 
DIRECTOR
SYNLOGIC, LLC   |  CRITICAL OUTCOME TECHNOLOGIES INC.   |  AKILI INTERACTIVE LABS, INC.   |  VEDANTA BIOSCIENCES, INC.   |  SEAPORT THERAPEUTICS, INC.
DANIEL 
 
COUTO 
EXECUTIVE OFFICER
VEDANTA BIOSCIENCES, INC.
SUSAN 
 
DILLON 
DIRECTOR
VEDANTA BIOSCIENCES, INC.
MARTIN 
 
HEIDECKER 
DIRECTOR
ARMAGEN TECHNOLOGIES INC   |  SENTIEN BIOTECHNOLOGIES, INC.   |  TILOS THERAPEUTICS, INC.   |  ABEXXA BIOLOGICS, INC.   |  ARMAGEN, INC.   |  RGENTA THERAPEUTICS, INC.   |  VENATORX PHARMACEUTICALS, INC.   |  VEDANTA BIOSCIENCES, INC.   |  ADAPTIVE PHAGE THERAPEUTICS, INC.   |  ELION THERAPEUTICS, INC.
TROY 
 
IGNELZI 
DIRECTOR
JUVENTAS THERAPEUTICS INC   |  SCPHARMACEUTICALS INC.   |  VEDANTA BIOSCIENCES, INC.
CURT 
 
LABELLE 
DIRECTOR
SAFEOP SURGICAL, INC.   |  EXAGEN DIAGNOSTICS INC   |  KUROBE PHARMACEUTICALS, INC.   |  EYENOVIA, INC.   |  INPRESS TECHNOLOGIES, INC.   |  REVELATION BIOSCIENCES, INC   |  OPHIREX, INC.   |  CXL OPHTHALMICS, INC.   |  VEDANTA BIOSCIENCES, INC.   |  RESOLUTE RESOURCES LTD./CAN   |  NOVOCUFF, INC.
JOHN 
 
LAMATTINA 
DIRECTOR
GELESIS INC   |  LIGAND PHARMACEUTICALS INC   |  IMMUNOME INC.   |  VEDANTA BIOSCIENCES, INC.
JOHN 
L 
LAMATTINA 
DIRECTOR
VEDANTA BIOSCIENCES, INC.
JOHN 
L. 
LAMATTINA 
DIRECTOR
VEDANTA BIOSCIENCES, INC.
MARK 
 
MULLIKIN 
EXECUTIVE OFFICER
VEDANTA BIOSCIENCES, INC.
BERNAT 
 
OLLE 
EXECUTIVE OFFICER, DIRECTOR
VEDANTA BIOSCIENCES, INC.
BENNETT 
 
SHAPIRO 
DIRECTOR
SATORI PHARMACEUTICALS INC   |  VEDANTA BIOSCIENCES, INC.
BENNETT 
M 
SHAPIRO 
DIRECTOR
VEDANTA BIOSCIENCES, INC.
BENNETT 
M. 
SHAPIRO 
DIRECTOR
VEDANTA BIOSCIENCES, INC.
CHARLES 
 
SHERWOOD 
DIRECTOR
VEDANTA BIOSCIENCES, INC.
JEFFREY 
 
SILBER 
EXECUTIVE OFFICER
VEDANTA BIOSCIENCES, INC.
NEIL 
 
TIWARI 
DIRECTOR
CALA HEALTH, INC.   |  MEKONOS, INC.   |  VIRB INC   |  VEDANTA BIOSCIENCES, INC.
CHRISTOPHER 
 
VIEHBACHER 
DIRECTOR
MACROLIDE PHARMACEUTICALS, INC.   |  VEDANTA BIOSCIENCES, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2024-08-05
D/A
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Debt 
2023-03-01 
2023-05-02
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Debt 
2023-03-01 
2021-08-13
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-07-16 
2019-09-19
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2019-09-11 
2019-05-08
D/A
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2018-12-21 
2019-03-28
D/A
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2018-12-21 
2019-02-05
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2018-12-21 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
FJS CONSULTANTS LIMITED
NONE
NONE
NONE
CHINA ECAPITAL PARTNERS, LLC
150251